Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1693

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 7A
Chunk 1693
---
 their respective disclosures.

NOTE 10–SUBSEQUENT EVENTS 

The Company evaluated subsequent events to
determine if events or transactions occurred after the balance sheet date up to the date the consolidated financial statements were
issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated
financial statements, other than the following:

Annual Meeting of Stockholders

On February 13, 2025, the Company held a special
meeting of its stockholders (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved several
proposals to amend the Company’s Charter. The stockholders approved the business combination (the “Business Combination”)
reflected by the Amended and Restated Business Combination Agreement, dated May 23, 2024, as amended on December 20, 2024 (the “Business
Combination Agreement”). The stockholders also approved to change Bellevue Life Sciences Acquisition Corp.’s name to “OSR,
Inc.” The stockholders also approved to increase the number of shares of preferred stock that can be issued from 1,000,000 shares
to 20,000,000 shares. The stockholders also approved to provide that directors may be removed by the affirmative vote of the holders of
at least 66 2/3% of the voting power instead of for cause and by the affirmative vote of holders of a majority of the voting power. The
stockholders also approved to eliminate the current limitations on the corporate opportunity doctrine. The stockholders also approved
to provide that the quorum required for stockholder meetings is the holders of one-third in voting power of then outstanding shares of
capital stock entitled to vote at the meeting instead of the holders of a majority in voting power of then outstanding shares of capital
stock entitled to vote at the meeting. The stockholders also approved to all other changes including eliminating certain provisions related
to special purpose acquisition companies that will no longer be relevant following the closing of the Business Combination. The stockholders
also approved to elect nine (9) individuals as directors of OSR, Inc. following the closing of the Business Combination until their respective
successors are duly elected and qualified. The stockholders also approved, for purposes of complying with the applicable listing rules
of the Nasdaq Stock Market LLC, the issuance of shares of OSR, Inc. common stock pursuant to the Business Combination Agreement in connection
with the Business Combination. In connection with the votes to approve the Adjournment Proposal,